Scotch Plains, NJ, United States of America

Bunnie M Ashe

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bunnie M Ashe. Retrieved from https://idiyas.com/inventor/bunnie-m-ashe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bunnie M Ashe: Innovator in Anti-Inflammatory Research

Introduction

Bunnie M Ashe is a notable inventor based in Scotch Plains, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. Her work has led to advancements that benefit both the medical community and patients alike.

Latest Patents

Bunnie M Ashe holds 1 patent for her innovative work titled "Cephalosporin derivatives as anti-inflammatory agents." This patent focuses on derivatives of cephalosporin esters, which have been identified as potent elastase inhibitors. These compounds are valuable in the treatment of inflammation, showcasing her expertise in medicinal chemistry.

Career Highlights

Bunnie M Ashe is currently employed at Merck & Co., Inc., a leading global healthcare company. Her role at Merck has allowed her to collaborate with other talented professionals in the field. Her contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Throughout her career, Bunnie has worked alongside esteemed colleagues such as Morris Zimmerman and James B Doherty. These collaborations have fostered an environment of innovation and have led to significant breakthroughs in their respective areas of research.

Conclusion

Bunnie M Ashe's work in developing anti-inflammatory agents exemplifies her dedication to improving healthcare through innovation. Her contributions to the field are noteworthy and continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…